MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

IMVT_BIG-svg

Immunovant, Inc. (IMVT)

IMVT_BIG-svg

Immunovant, Inc. (IMVT)

|||

Balance Sheets Overview

Current Ratio
726.87%
Quick Ratio
726.87%
Cash Ratio
681.28%
Debt to Asset Ratio
13.74%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Other assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
797,798
902,110
994,525
521,870
Accounts receivable
697
1,133
1,643
1,970
Prepaid expenses and other current assets
52,683
42,763
46,771
49,706
Income tax receivable
-
2,813
-
-
Total current assets
851,178
948,819
1,042,939
573,546
Operating lease right-of-use assets
-
72
-
-
Property and equipment, net
351
443
531
632
Other assets
961
7,680
8,922
8,781
Total assets
852,490
957,014
1,052,392
582,959
Accounts payable
10,138
7,541
8,616
6,916
Accrued expenses
-
96,634
-
-
Current portion of operating lease liabilities
-
72
-
-
Due to roivant sciences ltd
-
175
-
-
Accrued expenses and other current liabilities
106,964
-
57,641
56,338
Total current liabilities
117,102
104,422
66,257
63,254
Total liabilities
117,102
104,422
66,257
63,254
Preferred stock-Series APreferred Stock
0
0
0
0
Preferred stock-Preferred Stock Excluding Series APreferred Stock
0
0
0
0
Common stock, par value 0.0001 per share, 500,000,000 shares authorized, 206,264,878 shares issued and outstanding at june30, 2026 and 500,000,000 shares authorized, 203,940,353 shares issued and outstanding at march31, 2026
20
20
20
17
Additional paid-in capital
2,632,996
2,596,971
2,582,191
2,004,876
Accumulated other comprehensive income
725
730
1,197
1,450
Accumulated deficit
-1,898,353
-1,745,129
-1,597,273
-1,486,638
Total stockholders equity
735,388
852,592
986,135
519,705
Total liabilities and stockholders equity
852,490
957,014
1,052,392
582,959
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$797,798K (33.21%↑ Y/Y)Prepaid expenses andother current assets$52,683K (3.47%↑ Y/Y)Accounts receivable$697K (-64.00%↓ Y/Y)Total current assets$851,178K (30.60%↑ Y/Y)Other assets$961K (-89.25%↓ Y/Y)Property and equipment,net$351K (-52.37%↓ Y/Y)Total assets$852,490K (28.88%↑ Y/Y)Total liabilities andstockholders equity$852,490K (28.88%↑ Y/Y)Total stockholdersequity$735,388K (20.84%↑ Y/Y)Total liabilities$117,102K (121.36%↑ Y/Y)Accumulated deficit-$1,898,353K (-39.57%↓ Y/Y)Additional paid-in capital$2,632,996K (33.86%↑ Y/Y)Total currentliabilities$117,102K (121.36%↑ Y/Y)Accumulated othercomprehensive income$725K (-58.26%↓ Y/Y)Common stock, par value0.0001 per share,...$20K (25.00%↑ Y/Y)Accrued expenses andother current...$106,964K (137.40%↑ Y/Y)Accounts payable$10,138K (29.26%↑ Y/Y)